Health
First Randomized Trial Reassures on ACEIs, ARBs in COVID-19 – Medscape
The BRACE CORONA study found no difference in key outcomes between patients continuing vs stopping their medication.
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
The first randomized study to compare continuing vs stopping angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for patients with COVID-19 has shown no difference in key outcomes between the two approaches.
The BRACE CORONA trial conducted in patients had been taking an ACE inhibitor or an ARB on a long-term basis and who were subsequently hospitalized with C…
-
Noosa News22 hours agoWhat the numbers really say about Crisafulli’s crime crackdown
-
Noosa News19 hours agoTwo bodies found in search for missing Brisbane couple in Tasmania
-
General24 hours agoHMAS Canberra accidentally blocks wireless internet and radio services in New Zealand
-
General22 hours agoThe US dollar’s demise has consequences for Australia